Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function

Hippocampus

Volumn 22, Issue 2, 2012, Pages 230-240

  Balu, Darrick T ^a,b   Carlson, Gregory C ^a   Talbot, Konrad ^a   Kazi, Hala ^a   Hill Smith, Tiffany E ^a   Easton, Rachel M ^a   Birnbaum, Morris J ^a   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

Akt; Cognition; Hippocampus; Learning and memory; Neurogenesis; Schizophrenia

Indexed keywords

AKT1 PROTEIN; DOPAMINE; ISOENZYME; NORADRENALIN; PROTEIN SERINE THREONINE KINASE; SEROTONIN; UNCLASSIFIED DRUG;

AGED; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY STIMULATION; AUTOPSY; BRAIN FUNCTION; BRAIN STEM; CELL PROLIFERATION; CLINICAL ARTICLE; CONDITIONING; CONTROLLED STUDY; DENTATE GYRUS; ENZYME DEFICIENCY; ENZYME PHOSPHORYLATION; FEAR; FEMALE; FRONTAL CORTEX; GENE DELETION; HIPPOCAMPUS; HIPPOCAMPUS POTENTIAL; HUMAN; HUMAN CELL; HUMAN TISSUE; LOCOMOTION; MALE; MOUSE; NERVE CELL; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPHYSIOLOGY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECALL; SCHIZOPHRENIA; SENSORY GATING; SPATIAL MEMORY; STARTLE REFLEX; STEM CELL;

AGED; AGED, 80 AND OVER; ANIMALS; BEHAVIOR, ANIMAL; CELL PROLIFERATION; CONDITIONING, CLASSICAL; FEAR; FEMALE; HIPPOCAMPUS; HUMANS; LEARNING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONAL PLASTICITY; PROTO-ONCOGENE PROTEINS C-AKT; SCHIZOPHRENIA; SPATIAL BEHAVIOR; STARTLE REACTION;

EID: 84856099280     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20887     Document Type: Article

References (51)

1. Bajestan SN, Sabouri AH, Nakamura M, Takashima H, Keikhaee MR, Behdani F, Fayyazi MR, Sargolzaee MR, Bajestan MN, Sabouri Z, Khayami E, Haghighi S, Hashemi SB, Eiraku N, Tufani H, Najmabadi H, Arimura K, Sano A, Osame M. 2006. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am J Med Genet B Neuropsychiatr Genet 141B: 383-386.
2. Balu DT, Hodes GE, Hill TE, Ho N, Rahman Z, Bender CN, Ring RH, Dwyer JM, Rosenzweig-Lipson S, Hughes ZA, Schechter LE, Lucki I. 2009. Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse. J Pharmacol Toxicol Methods 59: 100-107.
3. Balu DT, Lucki I. 2009. Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology. Neurosci Biobehav Rev 33: 232-252.
4. Barch DM. 2005. The cognitive neuroscience of schizophrenia. Annu Rev Clin Psychol 1: 321-353.
5. Bast T, Feldon J. 2003. Hippocampal modulation of sensorimotor processes. Prog Neurobiol 70: 319-345.
6. Beaulieu JM, Gainetdinov RR, Caron MG. 2009. Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49: 327-347.
7. Brunet A, Datta SR, Greenberg ME. 2001. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11: 297-305.
8. Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL. 2000. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: Evidence of inhibitory deficits. Am J Psychiatry 157: 1660-1668.
9. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. 2001. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276: 38349-38352.
10. Coffer PJ, Jin J, Woodgett JR. 1998. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335 (Pt 1): 1-13.
11. Consortium IS. 2008. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455: 237-241.
12. Dummler B, Hemmings BA. 2007. Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans 35 (Pt 2): 231-235.
13. Dupret D, Revest JM, Koehl M, Ichas F, De Giorgi F, Costet P, Abrous DN, Piazza PV. 2008. Spatial relational memory requires hippocampal adult neurogenesis. PLoS ONE 3: e1959
14. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. 2004. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36: 131-137.
15. Hanlon FM, Weisend MP, Hamilton DA, Jones AP, Thoma RJ, Huang M, Martin K, Yeo RA, Miller GA, Canive JM. 2006. Impairment on the hippocampal-dependent virtual Morris water task in schizophrenia. Schizophr Res 87: 67-80.
16. Harrison PJ. 2004. The hippocampus in schizophrenia: A review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174: 151-162.
17. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10: 40-68.
18. Hetherington PA, Austin KB, Shapiro ML. 1994. Ipsilateral associational pathway in the dentate gyrus: An excitatory feedback system that supports N-methyl-D-aspartate-dependent long-term potentiation. Hippocampus 4: 422-438.
19. Horwood JM, Dufour F, Laroche S, Davis S. 2006. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci 23: 3375-3384.
20. Ide M, Ohnishi T, Murayama M, Matsumoto I, Yamada K, Iwayama Y, Dedova I, Toyota T, Asada T, Takashima A, Yoshikawa T. 2006. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. J Neurochem 99: 277-287.
21. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Inada T, Ozaki N. 2004. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry 56: 698-700.
22. Kalkman HO. 2006. The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol Ther 110: 117-134.
23. Lai WS, Xu B, Westphal KG, Paterlini M, Olivier B, Pavlidis P, Karayiorgou M, Gogos JA. 2006. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci U S A 103: 16906-16911.
24. Lewis DA, Gonzalez-Burgos G. 2008. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33: 141-165.
25. Li BS, Ma W, Jaffe H, Zheng Y, Takahashi S, Zhang L, Kulkarni AB, Pant HC. 2003. Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J Biol Chem 278: 35702-35709.
26. Li Y, Luikart BW, Birnbaum S, Chen J, Kwon CH, Kernie SG, Bassel-Duby R, Parada LF. 2008. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 59: 399-412.
27. Liu YL, Fann CS, Liu CM, Wu JY, Hung SI, Chan HY, Chen JJ, Pan CC, Liu SK, Hsieh MH, others. 2006. Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population. Psychiatr Genet 16: 39-41.
28. Manning BD, Cantley LC. 2007. AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274.
29. Numakawa T, Yagasaki Y, Ishimoto T, Okada T, Suzuki T, Iwata N, Ozaki N, Taguchi T, Tatsumi M, Kamijima K, Straub RE, Weinberger DR, Kunugi H, Hashimoto R. 2004. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 13: 2699-2708.
30. O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I. 2007. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology (Berl) 192: 357-371.
31. Ohtsuki T, Inada T, Arinami T. 2004. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol Psychiatry 9: 981-983.
32. Patapoutian A, Reichardt LF. 2001. Trk receptors: Mediators of neurotrophin action. Curr Opin Neurobiol 11: 272-280.
33. Reif A, Fritzen S, Finger M, Strobel A, Lauer M, Schmitt A, Lesch KP. 2006. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 11: 514-522.
34. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. 2006. Neurobiology of schizophrenia. Neuron 52: 139-153.
35. Sanders MJ, Wiltgen BJ, Fanselow MS. 2003. The place of the hippocampus in fear conditioning. Eur J Pharmacol 463: 217-223.
36. Saxe MD, Battaglia F, Wang JW, Malleret G, David DJ, Monckton JE, Garcia AD, Sofroniew MV, Kandel ER, Santarelli L, Hen R, Drew MR. 2006. Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proc Natl Acad Sci U S A 103: 17501-17506.
37. Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B, Trixler M, Maier W, Wildenauer DB. 2005. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 58: 446-450.
38. Sharma T, Antonova L. 2003. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr Clin North Am 26: 25-40.
39. Snyder JS, Choe JS, Clifford MA, Jeurling SI, Hurley P, Brown A, Kamhi JF, Cameron HA. 2009. Adult-born hippocampal neurons are more numerous, faster maturing, and more involved in behavior in rats than in mice. J Neurosci 29: 14484-14495.
40. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Jonasdottir A, Bjornsson A, Mattiasdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Möller HJ, Hartmann A, Shianna KV, Ge D, Need AC, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Paunio T, Toulopoulou T, Bramon E, Di Forti M, Murray R, Ruggeri M, Vassos E, Tosato S, Walshe M, Li T, Vasilescu C, Mühleisen TW, Wang AG, Ullum H, Djurovic S, Melle I, Olesen J, Kiemeney LA, Franke B;GROUP, Sabatti C, Freimer NB, Gulcher JR, Thorsteinsdottir U, Kong A, Andreassen OA, Ophoff RA, Georgi A, Rietschel M, Werge T, Petursson H, Goldstein DB, Nöthen MM, Peltonen L, Collier DA, St Clair D, Stefansson K. 2008. Large recurrent microdeletions associated with schizophrenia. Nature 455: 232-236.
41. Swerdlow NR, Geyer MA. 1998. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24: 285-301.
42. Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, Hahn CG, Siegel SJ, Trojanowski JQ, Gur RE, Blake DJ, Arnold SE. 2004. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 113: 1353-1363.
43. Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, Fanous A, O'Neill FA, Walsh D, Van den Oord EJ, Kendler KS, Riley BP. 2008. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry 63: 449-457.
44. Turunen JA, Peltonen JO, Pietilainen OP, Hennah W, Loukola A, Paunio T, Silander K, Ekelund J, Varilo T, Partonen T, Lönnqvist J, Peltonen L. 2007. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Schizophr Res 91: 27-36.
45. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539-543.
46. Weinberger DR. 1999. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 45: 395-402.
47. Winocur G, Wojtowicz JM, Sekeres M, Snyder JS, Wang S. 2006. Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 16: 296-304.
48. Xie X, Liaw JS, Baudry M, Berger TW. 1997. Novel expression mechanism for synaptic potentiation: alignment of presynaptic release site and postsynaptic receptor. Proc Natl Acad Sci U S A 94: 6983-6988.
49. Xu MQ, Xing QH, Zheng YL, Li S, Gao JJ, He G, Guo TW, Feng GY, Xu F, He L. 2007. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. J Clin Psychiatry 68: 1358-1367.
50. Zhao C, Deng W, Gage FH. 2008. Mechanisms and functional implications of adult neurogenesis. Cell 132: 645-660.
51. Zhao Z, Ksiezak-Reding H, Riggio S, Haroutunian V, Pasinetti GM. 2006. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr Res 84: 1-14.